Search results for: 'Cancer Diagnostics Market, liquid biopsy'
- Related search terms
- cancer vaccines market
- cancer immunotherapy global market
- liquid biopsy market trend
- diagnostics market outlook series
- cancer immunotherapi global market
-
22 Feb 2022  |  North America  |  Market Research
United States Liquid Biopsy Growth Opportunities
Non-invasive Liquid Biopsy Technology Shapes the Precision Diagnostics Landscape
Healthcare is rapidly becoming patient-centric, focusing on outcomes and value. This offers clinical diagnostics players opportunities to advance their instrument, assay, and informatics capabilities to address unmet clinical needs and increase the precision diagnostics portfolio. Advances in next-generation sequencing-based companion diagnosti...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Aug 2022  |  North America  |  Frost Radar
Frost Radar™: US Liquid Biopsy, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...
$4,950.00
Special Price $3,712.50 save 25 %
-
09 Oct 2024  |  North America  |  Technology Research
Innovations and Growth Opportunities in the Biopsy Industry, 2024 2028
Exploring Recent Developments and Emerging Opportunities in Solid Tissue Biopsy and Breath Biopsy Thanks to Advancements in Precision, Automation, and Connectivity
The biopsy device market s landscape is transforming due to technological advancements, evolving clinical needs, and the push for greater precision and minimally invasive approaches. In that context, this Frost & Sullivan analysis provides a comprehensive overview of different biopsy devices, with its main focus being solid tissue biopsy. In ad...
$4,950.00
Special Price $4,207.50 save 15 %
-
31 Jul 2023  |  North America  |  Market Research
Global Oncology Diagnostics in IVD Growth Opportunities
By Leveraging Data-driven Solutions, Co-development Opportunities, and Assay Innovation, Clients Can Experience Enhanced Product Performance, Cost-effectiveness, and Improved Decision-making Capabilities
The global oncology diagnostics in IVD market is expected to witness significant growth, driven by an increase in cancer incidence, technological developments in diagnostic tests, the growing number of screening tests, and supportive government initiatives. Owing to the intense competition in the market, the most prominent companies are investing h...
$4,950.00
Special Price $3,712.50 save 25 %
-
05 Oct 2018  |  North America  |  Market Research
Growth Opportunities in the Global Liquid Biopsy Market, 2018
Companies are Vying for a Higher Market Position in the Early Cancer Screening Market
Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...
$4,950.00
Special Price $3,712.50 save 25 %
-
10 May 2018  |  North America  |  Market Research
Global Tissue Diagnostics Market, Forecast to 2022
Liquid Biopsy for Therapy Monitoring and Reimbursement Cuts Impede Long-term Prospects of Tissue Diagnostics Market
Tissue diagnostic techniques are used to recognize specific antigens in preserved tissues. The process includes slicing thin tissue samples that are treated with a hematoxylin and eosin (H&E) stain, and then are formalin-fixed paraffin-embedded (FFPE) to diagnose tumors and other histopathology specimens. This has traditionally required skilled pat...
$4,950.00
Special Price $3,712.50 save 25 %
-
03 Dec 2024  |  North America  |  Technology Research
Technology Innovations and Growth Opportunities in Breast Cancer Diagnosis
Advancing Breast Cancer Diagnosis by Leveraging Acoustic and Nonionizing Radiation Technologies
Mammography and tissue biopsy have been the gold standard to detect breast cancer. Repeated mammography to assess the treatment response or disease prognosis results in frequent radiation exposure. In women with dense breasts In women with dense breasts, which have more fibrous and glandular tissues, mammograms show a white image similar to cancero...
$4,950.00
Special Price $4,207.50 save 15 %
-
09 Sep 2015  |  North America  |  Market Research
Product and Pipeline Analysis of the Global Colorectal Cancer Market
Targeted Therapeutics and Immunology Combine to Take Colorectal Cancer Treatments to the Next Level
This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies, and key companies to watch. The global market is primarily driven by the high prevalen...
$3,950.00
Special Price $2,962.50 save 25 %
-
24 Feb 2016  |  North America  |  Market Research
US Autoimmune Disease Diagnostics Market, Forecast to 2020
Systemic Autoimmune Diseases to Spur Double-digit Market Growth as Participants Look to Unmet Needs and Game-changing Strategies to Boost Revenues
According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as ...
$1,500.00
Special Price $1,125.00 save 25 %
-
23 May 2017  |  North America  |  Market Research
Growth Opportunities in the US In Vitro Diagnostics (IVD) Market, Forecast to 2021
US IVD Market Witnesses Pricing Fluctuations Due to the PAMA Regulation
The In Vitro Diagnostics (IVD) landscape in the United States is extremely dynamic, with a high level of merger and acquisition activity with many high-value deals still pending. Both clinical laboratories and manufacturers are increasingly vying for smaller specialized niche technology companies to increase their market share. Molecular point of c...
$4,950.00
Special Price $3,712.50 save 25 %